Skip to Main Content
CNE² - Center for Neuroepidemiology and Clinical Neurological Research
Yale Home

INFORMATION FOR

    Seminar and Events

    Upcoming

    Mar 202512Wednesday
    Apr 20259Wednesday
    May 202514Wednesday
    Jun 202511Wednesday
    See All Events
    Download The Calendar

    CNE2 Research Seminar Featured Speakers

    The Center for Neuroepidemiolgy and Clinical Neurological Research Seminar Series has featured the following speakers from the Center who have presented their latest research findings to members of the Department of Neurology. We invite you to read about their work below:
    Name Presentation Date Presentation Topic/Conclusion
    Richa Sharma, MD, MPH November 2, 2020 There were excess cerebrovascular-related deaths in the United States during the first wave of the COVID-19 pandemic. States with more restricted mobility experienced more cerebrovascular mortality even upon adjustment for COVID-19 deaths.
    Shelli Farhadian, MD, MPH November 2, 2020
    Allison E. Gaffey, PhD December 7, 2020 "Investigating Post-traumatic Stress Disorder as a Nontraditional Vascular Risk Factor among Younger Adults"
    Kevin Sheth, MD December 7, 2020 "Point-of-Care, Bedside MRI for Acute Brain Injury"
    Carolyn Fredericks, MD January 4, 2021 "When It's Not About Memory: Multimodal Neuroimaging Approaches to Understanding Dose Psilocybin in Migraine and Cluster Headache"
    Emmanuelle Schinder, MD, PhD January 4, 2021 "Sustained Reductions in Headache Burden after the Limited Administration of Low Dose Psilocybin in Migraine and Cluster Headache"
    Ben Tolchin, MD, MS February 1, 2021 "The Impact of Crisis Standards of Care and Triage Protocols on Racial Health Disparities"
    Shelli Farhadian, MD, PhD February 1, 2021 We analyzed paired spinal fluid and blood of hospitalized patients with acute COVID-19 and found evidence for divergent immunological responses in the central nervous system. Through single cell and complementary assays, we find evidence for a CNS-specific T and B cell response in the CNS, including a high burden of anti-neural autoantibodies in the CSF of patients with COVID-19 and neurological symptoms.
    Brenda Fenton, PhD, M.Sc, Associate Director of our HCoE Research & Evaluation Center March 1, 2021 "The Veterans Health Administration's Response to the COVID-19 Pandemic - preserving Headache Care Access"
    Tiffany Chang, MPH, PhD, Student, Department of Chronic Disease Epidemiology, Yale School of Public Health March 1, 2021 "Examining the Relationship between Cardiovascular Risk Factor Profiles and Hospital Visits for Women and Men with a History of Stroke or TIA"
    Adam Mecca, MD, PhD April 5, 2021 "Novel Biomarkers of Synaptic Health in Alzheimer's Disease"
    Hamada Hamid Altalib, DO, MPH April 5, 2021
    Jason Sico, MD May 3, 2021 "Understanding Ischemic Stroke Care within the Veterans Health Administration and an Introduction to VHA Data Sources"
    Jennifer A. Kim, MD, PhD May 3, 2021
    Amy Grinberg, PhD, VA Connecticut Healthcare System, Headache Centers of Excellence Program October 4, 2021 Behavioral interventions for headache
    Elizabeth Seng, PhD, Associate Professor of Health Psychology at Yeshiva University and of Neurology at Albert Einstein College of Medicine November 1, 2021 "The Promise and Perils of using Mobile Health Apps to Gain Scientific Knowledge about Migraine"
    Serena Spudich, MD December 6, 2021 "What do we Know to Date about Post-COVID Neurologic Symptoms? Preliminary Insights from the COVID Mind Study at Yale